시장보고서
상품코드
1193136

노상 약물 검사 기기 시장 : 샘플 유형별(타액, 호기, 기타), 물질별(약물, 알코올), 최종사용자별(고속도로경찰, 마약단속국) - 세계 기회 분석 및 산업 예측(2021-2031년)

Roadside Drug Testing Devices Market By Sample Type (Saliva, Breath, Others), By Substance (Drugs, Alcohol), By End User (Highway Police, Drug Enforcement Agencies): Global Opportunity Analysis and Industry Forecast, 2021-2031

발행일: | 리서치사: Allied Market Research | 페이지 정보: 영문 203 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

노상 약물 검사 기기 시장은 2021년 4억 2176만 달러로, 2031년 7억 728만 달러에 이를 것으로 예측되며, 2022년부터 2031년까지의 CAGR은 5.3%로 성장할 것으로 추정된다.

거리에서의 약물 검사는 소변, 혈액, 땀, 호기 등의 샘플을 사용하여 신체의 약물 흔적을 찾는 것을 의미합니다. 약물 검사 또는 약물 스크리닝 검사를 통과하는 것은 약물이 체내에 존재하지 않거나 존재하더라도 매우 적은 양임을 의미합니다. 마약과 알코올의 영향은 명확한 시력과 신속한 영적 기능을 가진 방해로, 도로 약물 검사의이 유형은 자동차 운전자의 안전을 보장하기 위해 실시되었습니다.

노상 약물 검사는 종종 차량 운전자의 타액과 호기 샘플을 취하여 수행됩니다. 음주 감지기로 알려진 장치는 테스터의 폐에 깊은 숨을 사용하여 혈액에서 알코올의 존재를 감지합니다. 타액은 최근 약물 사용을 식별하는 데 더 효과적입니다. 그러나 타액을 사용한 약물 검사는 IT·통신부에서의 사용이나 연방 정부가 의무화하는 약물 검사로 식품의약품국에서 승인되지 않았다는 단점이 있습니다.

전세계 음료와 드라이브의 유병률 증가는 노상 약물 검사 기기 시장의 성장을 추진하고 있습니다. 예를 들어 2019년 알코올 남용과 알코올 중독에 관한 국립연구소의 보고서에 따르면 10,142명이 음주운전의 결과로 그들의 삶을 잃었다.

노상 약물 검사 기기 시장은 표본 유형, 물질 유형 및 최종 사용자를 기준으로 분류됩니다. 샘플 유형별로 시장은 타액, 호기 등으로 나뉩니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 개요

  • 시장의 정의와 범위
  • 주요 조사 결과
    • 주요 투자 포켓
  • Porter's Five Forces 분석
  • 주요 기업의 포지셔닝
  • 시장 역학
    • 촉진 요인
    • 억제 요인
    • 기회
  • COVID-19 영향 분석

제4장 노상 약물 검사 기기 시장 : 검체 유형별

  • 개요
    • 시장 규모 및 예측
  • 타액
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모 및 예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 호흡기
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 기타
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별

제5장 노상 약물 검사 기기 시장 : 물질별

  • 개요
    • 시장 규모·예측
  • 약물
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모 및 예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 알코올
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별

제6장 노상 약물 검사 기기 시장 : 최종 사용자별

  • 개요
    • 시장 규모·예측
  • 고속도로 경찰
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 마약 단속 기관
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별

제7장 노면 약물 검사 장치 시장 : 지역별

  • 개요
    • 시장 규모·예측
  • 북미
    • 주요 동향과 기회
    • 북미 시장 규모·예측 : 샘플 유형별
    • 북미의 시장 규모·예측 : 물질별
    • 북미 시장 규모·예측 : 최종 사용자별
    • 북미 시장 규모·예측 : 국가별
      • 미국
      • 캐나다
      • 멕시코
  • 유럽
    • 주요 동향과 기회
    • 유럽 시장 규모·예측 : 샘플 유형별
    • 유럽 시장 규모·예측 : 물질별
    • 유럽 시장 규모·예측 : 최종 사용자별
    • 유럽 시장 규모·예측 : 국가별
      • 독일
      • 프랑스
      • 영국
      • 이탈리아
      • 스페인
      • 기타 유럽
  • 아시아태평양
    • 주요 동향과 기회
    • 아시아태평양의 시장 규모·예측 : 샘플 유형별
    • 아시아태평양의 시장 규모·예측 : 물질별
    • 아시아태평양의 시장 규모·예측 : 최종 사용자별
    • 아시아태평양의 시장 규모·예측 : 국가별
      • 일본
      • 중국
      • 호주
      • 인도
      • 한국
      • 기타 아시아태평양
  • LAMEA
    • 주요 동향과 기회
    • LAMEA의 시장 규모·예측 : 샘플 유형별
    • LAMEA의 시장 규모·예측 : 물질별
    • LAMEA의 시장 규모·예측 : 엔드유저별
    • LAMEA의 시장 규모·예측 : 국가별
      • 브라질
      • 사우디아라비아
      • 남아프리카 공화국
      • 기타 LAMEA 지역

제8장 기업 정세

  • 소개
  • 주요 성공 전략
  • 주요 10개사의 제품 매핑
  • 경쟁 대시보드
  • 경합의 히트 맵
  • 주요 발전

제9장 기업 프로필

  • Abbott Laboratories
  • AK GlobalTech Corporation
  • Alcohol Countermeasure Systems Corp.
  • Cannabix Technologies Inc.
  • Drager
  • Intelligent Fingerprinting
  • Lifeloc Technologies, Inc.
  • Oranoxis Inc.
  • Thermo Fisher Scientific, Inc.
  • UriTox LLC.
ksm 23.03.27

The roadside drug testing devices market was valued at 421.76 million in 2021, and is projected to reach $707.28 million by 2031 registering a CAGR of 5.3%from 2022 to 2031  

The roadside drug testing refers to looking for traces of drugs in the body using samples of urine, blood, sweat or breath. Passing of drug testing or drug screening tests means that the drug might not be present in the body anymore or presence is in very small amount. This type of roadside drug testing is conducted to ensure safety of the motor vehicle drivers, as influence of drugs and/or alcohol hinders with clear sight and quick mental function. 

Roadside drug testing is often done either by taking sample saliva or breath of the vehicle driver. The device, which is known as breathalyzer, uses deep-lung breath of the tester and thus, detects presence of alcohol in blood. Saliva is more effective at identifying most recent drug usage. However, saliva-based drug testing has the drawback that it is neither Food and Drug Administration approved for use with Department of Telecommunications nor federally mandated drug testing.  

Increase in prevalence of drink and drive all over the globe, propel the growth of the roadside drug testing devices market. For instance, according to a report by the National Institute on Alcohol Abuse and Alcoholism in 2019, 10,142 people lost their lives as a result of drunk driving.  

The roadside drug testing devices market is segmented on the basis of sample type, substance type, and end user. As per sample type, the market is divided into saliva, breath, and others. 

By end user, the market is divided into highway police and drug enforcement agencies. On the basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

  • The major companies profiled in the report include, AK GlobalTech Corp., Abbott Laboratories, Drager, Alcohol Countermeasure Systems Corp., Cannabix Technologies Inc., Intelligent Fingerprinting, Lifeloc Technologies, Inc., Oranoxis Inc., Thermo Fisher Scientific, Inc., and UriTox LLC.
  • Key Benefits For Stakeholders
  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the roadside drug testing devices market analysis from 2021 to 2031 to identify the prevailing roadside drug testing devices market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the roadside drug testing devices market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global roadside drug testing devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Sample Type

  • Saliva
  • Breath
  • Others

By Substance

  • Drugs
  • Alcohol

By End User

  • Highway Police
  • Drug Enforcement Agencies

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Drager
    • Alcohol Countermeasure Systems Corp.
    • AK GlobalTech Corporation
    • Cannabix Technologies Inc.
    • Intelligent Fingerprinting
    • Lifeloc Technologies, Inc.
    • Oranoxis Inc.
    • Thermo Fisher Scientific, Inc.
    • UriTox LLC.
    • Abbott Laboratories

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Saliva
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3 Breath
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country
  • 4.4 Others
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market share analysis by country

CHAPTER 5: ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Drugs
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3 Alcohol
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country

CHAPTER 6: ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Highway Police
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market share analysis by country
  • 6.3 Drug Enforcement Agencies
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market share analysis by country

CHAPTER 7: ROADSIDE DRUG TESTING DEVICES MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Sample Type
    • 7.2.3 North America Market size and forecast, by Substance
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Key market trends, growth factors and opportunities
      • 7.2.5.1.2 Market size and forecast, by Sample Type
      • 7.2.5.1.3 Market size and forecast, by Substance
      • 7.2.5.1.4 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Key market trends, growth factors and opportunities
      • 7.2.5.2.2 Market size and forecast, by Sample Type
      • 7.2.5.2.3 Market size and forecast, by Substance
      • 7.2.5.2.4 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Key market trends, growth factors and opportunities
      • 7.2.5.3.2 Market size and forecast, by Sample Type
      • 7.2.5.3.3 Market size and forecast, by Substance
      • 7.2.5.3.4 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Sample Type
    • 7.3.3 Europe Market size and forecast, by Substance
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Key market trends, growth factors and opportunities
      • 7.3.5.1.2 Market size and forecast, by Sample Type
      • 7.3.5.1.3 Market size and forecast, by Substance
      • 7.3.5.1.4 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Key market trends, growth factors and opportunities
      • 7.3.5.2.2 Market size and forecast, by Sample Type
      • 7.3.5.2.3 Market size and forecast, by Substance
      • 7.3.5.2.4 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Key market trends, growth factors and opportunities
      • 7.3.5.3.2 Market size and forecast, by Sample Type
      • 7.3.5.3.3 Market size and forecast, by Substance
      • 7.3.5.3.4 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Key market trends, growth factors and opportunities
      • 7.3.5.4.2 Market size and forecast, by Sample Type
      • 7.3.5.4.3 Market size and forecast, by Substance
      • 7.3.5.4.4 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Key market trends, growth factors and opportunities
      • 7.3.5.5.2 Market size and forecast, by Sample Type
      • 7.3.5.5.3 Market size and forecast, by Substance
      • 7.3.5.5.4 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Key market trends, growth factors and opportunities
      • 7.3.5.6.2 Market size and forecast, by Sample Type
      • 7.3.5.6.3 Market size and forecast, by Substance
      • 7.3.5.6.4 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Sample Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Substance
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Key market trends, growth factors and opportunities
      • 7.4.5.1.2 Market size and forecast, by Sample Type
      • 7.4.5.1.3 Market size and forecast, by Substance
      • 7.4.5.1.4 Market size and forecast, by End User
      • 7.4.5.2 China
      • 7.4.5.2.1 Key market trends, growth factors and opportunities
      • 7.4.5.2.2 Market size and forecast, by Sample Type
      • 7.4.5.2.3 Market size and forecast, by Substance
      • 7.4.5.2.4 Market size and forecast, by End User
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Key market trends, growth factors and opportunities
      • 7.4.5.3.2 Market size and forecast, by Sample Type
      • 7.4.5.3.3 Market size and forecast, by Substance
      • 7.4.5.3.4 Market size and forecast, by End User
      • 7.4.5.4 India
      • 7.4.5.4.1 Key market trends, growth factors and opportunities
      • 7.4.5.4.2 Market size and forecast, by Sample Type
      • 7.4.5.4.3 Market size and forecast, by Substance
      • 7.4.5.4.4 Market size and forecast, by End User
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Key market trends, growth factors and opportunities
      • 7.4.5.5.2 Market size and forecast, by Sample Type
      • 7.4.5.5.3 Market size and forecast, by Substance
      • 7.4.5.5.4 Market size and forecast, by End User
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Key market trends, growth factors and opportunities
      • 7.4.5.6.2 Market size and forecast, by Sample Type
      • 7.4.5.6.3 Market size and forecast, by Substance
      • 7.4.5.6.4 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Sample Type
    • 7.5.3 LAMEA Market size and forecast, by Substance
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Key market trends, growth factors and opportunities
      • 7.5.5.1.2 Market size and forecast, by Sample Type
      • 7.5.5.1.3 Market size and forecast, by Substance
      • 7.5.5.1.4 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Key market trends, growth factors and opportunities
      • 7.5.5.2.2 Market size and forecast, by Sample Type
      • 7.5.5.2.3 Market size and forecast, by Substance
      • 7.5.5.2.4 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Key market trends, growth factors and opportunities
      • 7.5.5.3.2 Market size and forecast, by Sample Type
      • 7.5.5.3.3 Market size and forecast, by Substance
      • 7.5.5.3.4 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Key market trends, growth factors and opportunities
      • 7.5.5.4.2 Market size and forecast, by Sample Type
      • 7.5.5.4.3 Market size and forecast, by Substance
      • 7.5.5.4.4 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Abbott Laboratories
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 AK GlobalTech Corporation
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Alcohol Countermeasure Systems Corp.
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Cannabix Technologies Inc.
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Drager
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Intelligent Fingerprinting
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Lifeloc Technologies, Inc.
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Oranoxis Inc.
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Thermo Fisher Scientific, Inc.
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 UriTox LLC.
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제